Location History:
- Oxfordshire, GB (2015)
- Abingdon, GB (2011 - 2017)
Company Filing History:
7 out of 19 
4 out of 230 
Years Active: 2011-2017
Title: Alan Hornsby Davidson: Innovator in Biochemistry
Introduction
Alan Hornsby Davidson, an esteemed inventor based in Abingdon, GB, holds an impressive portfolio of 11 patents. His work primarily focuses on biochemistry, specifically in the area of enzyme and receptor modulation, which has significant implications for therapeutic development.
Latest Patents
Among his latest patents, Davidson has contributed to the advancement of HDAC inhibitors. His formulation of compounds of formula (I) demonstrates the ability to inhibit HDAC activity through various substituents. These compounds explore the potential of modulating histone deacetylases, important targets in cancer therapy.
Additionally, he has developed covalent conjugates of alpha, alpha-disubstituted glycine esters that serve as modulators of intracellular enzymes and receptors. These conjugates are crafted to be hydrolysable by intracellular carboxylesterase enzymes, facilitating the accumulation of active compounds within cells, thus enhancing their therapeutic efficacy.
Career Highlights
Davidson's career includes significant roles at notable companies such as Chroma Therapeutics Limited and GlaxoSmithKline Intellectual Property Development Limited. His expertise in patent development has enabled him to make essential contributions to the field of biochemistry and therapeutic innovations.
Collaborations
Throughout his career, Davidson has collaborated with esteemed professionals in the industry, including David Festus Charles Moffat and Sanjay Ratilal Patel. These collaborations have fostered innovation and the development of groundbreaking patents in the biochemistry landscape.
Conclusion
Alan Hornsby Davidson stands out as a prominent inventor whose contributions to biochemistry through his patents have had a lasting impact on the field. His innovative approaches to understanding and modulating enzymatic activities continue to pave the way for new therapeutics and advancements in medical science.